Has Faisal Quereshy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $24,059 in general payments to Faisal Quereshy, MD across 261 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Faisal Quereshy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Faisal Quereshy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Faisal Quereshy, MD

Oral and Maxillofacial Surgery · Medina, OHNPI 1144316126

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (37.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Kls-martin L.p. at 32.5% of the total. Reporting peaked in 2019 at $11,794 and has fallen 91.7% since, to $978 in 2025. Among oral and maxillofacial surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,059in general payments, 2019–2025

Across 261 payments — averaging $92.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kls-martin L.p.$8K
Pacira Pharmaceuticals Incorporated$8K
Biohorizons Implant Systems Inc.$3K
Straumann USA LLC$3K
Stryker$1K
Nobel Biocare USA$343
plus $1K from 11 others

What the payments were for

Consulting fees$2,92512%
Speaking & faculty fees$9,04238%
Travel & lodging$5,36822%
Food & beverage$6,59927%
Education$1251%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kls-martin L.p.	19	$7,811
Pacira Pharmaceuticals Incorporated	2	$7,755
Biohorizons Implant Systems Inc.	158	$3,001
Straumann USA LLC	34	$2,830
Stryker	12	$1,255
Nobel Biocare USA	15	$343
Revance Therapeutics, Inc.	4	$313
Sonendo Inc	2	$197
Nexus Medical Technologies LLC	1	$166
Johnson & Johnson	1	$108
Axogen	1	$85
Geistlich Pharma, North America, Inc.	4	$54
ACE Surgical Supply Co., Inc.	3	$40
Southern Anesthesia & Surgical, Inc (dba ACE Southern)	2	$31
Zimmer Biomet	1	$27
Dentsply Sirona Inc	1	$24
Checkpoint Surgical, Inc	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,059 in reported general payments places this provider in the 95th percentile of 220 oral and maxillofacial surgery providers in Ohio.

See all oral and maxillofacial surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$14,395

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Penicillin V Potassium	83	$178
Chlorhexidine Gluconate	32	$105
Clindamycin Hcl	28	$86
Methylprednisolone	19	$85
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	33	$65
Ibuprofen	32	$51
Tramadol Hcl	52	$44

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Medina

Mohammad RazaviCleveland$41K
Robert HinkleDublin$21K
Jimmie HarperCincinnati$10K
Brian OneillBowling Green$9K
Timothy ConleyFairfield$9K
Gregory PlonaNorth Olmsted$8K
Jaclyn TomsicIndependence$8K
William BloodNorth Olmsted$8K
Matthew HoldshipToledo$7K
Patrick McCabeToledo$7K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →